Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

Melomanes Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Coordinator
Centre National De La Recherche Scientifique CNRS, France
Runs
1 March 2023 to 28 February 2027
Status
Running
EU funding
€2.7m
Total cost
—
Partners
26 organisations in 11 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101073025

What the project is doing

In the project's own words, from its summary on CORDIS.

Metastatic melanoma is a hard-to-treat disease and it remains as one of the most worrisome cancer. There is an urgent need to improve the current therapies (chemotherapy, radiotherapy) that have a limited efficacy. A single therapy is not efficient to tackle metastatic melanoma and a combination of therapies is thus emerging as a necessity to efficiently eradicate all cancer cells. Recently, the development of immunotherapies has shown promises, in particular chimeric antigen receptor (CAR)-T cells.

Nevertheless, the physical barriers represented by cellular and non-cellular components of the tumor microenvironment combined to the abnormal tumor vasculature and high interstitial fluid pressure, hamper an efficient tumour infiltration of CAR-T cells. In this context, thanks to a network of 18 partners (including 10 non-academic partners), MELOMANES aims to train doctoral researchers for the development of a combined therapy exploiting the properties of magnetic nanoparticles to induce damage on the tumor microenvironment by magnetic and optic hyperthermia in order to facilitate the infiltration of CAR-T cells.

This therapeutic approach combining hyperthermia and immunotherapy is versatile, as it could be also applied to other types of solid tumors. Research and transferable training of the doctoral researchers will be performed in a highly interdisciplinary, intersectoral, and international environment. In addition to acquiring skills related to the research project, they will be trained also in open science, communication and dissemination, responsible research and innovation, circular economy, ethics, data management, entrepreneurship, marketing, intellectual property, and gender dimension in research.

Their competences will be validated through certification and qualification examination, allowing a new generation of highly skilled doctoral researchers to emerge with a high-level training in particular in the multidisciplinary field of nanomedicine.

Topics

Who is involved

OrganisationCityCountryRole
Centre National De La Recherche Scientifique CNRSParisFranceCoordinator
Ecqa GmbHKrems An Der DonauAustriaAssociatedpartner
Lithoz GmbHWienAustriaAssociatedpartner
Universitat WienWienAustriaParticipant
Pepric NVLeuvenBelgiumAssociatedpartner
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandAssociatedpartner
Eidgenossische Materialprufungs- Und ForschungsanstaltDubendorfSwitzerlandAssociatedpartner
Novamechanics LimitedNicosiaCyprusParticipant
The Cyprus InstituteNicosiaCyprusAssociatedpartner
Fundacio Institut Catala De Nanociencia I NanotecnologiaBellaterra (Barcelona)SpainAssociatedpartner
Fundacion Instituto De Investigacion Marques De ValdecillaSantanderSpainParticipant
Universidad De CantabriaSantanderSpainAssociatedpartner
Misvik Biology OyTurkuFinlandParticipant
Turun YliopistoTurkuFinlandAssociatedpartner
Institut National De La Sante Et De La Recherche MedicaleParisFranceAssociatedpartner
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
InvectysParisFranceParticipant
Universite De StrasbourgStrasbourgFranceAssociatedpartner
Universite Paris CiteParisFranceAssociatedpartner
Malsch NeelinaUtrechtNetherlandsAssociatedpartner
Stichting VuAmsterdamNetherlandsParticipant
Oslo Universitetssykehus HfOsloNorwayParticipant
Universitetet I OsloOsloNorwayAssociatedpartner
First Five Consulting, S.A.LisboaPortugalAssociatedpartner
Cn Bio Innovations LimitedThameUnited KingdomAssociatedpartner
NanothericsKeele Newcastle Under LymeUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI